Article

Patients Play an Important Role in Cancer Treatment

While it is the responsibility of the clinician to inform their patients of all options available, it is, in turn, vital for them to play a role in selecting the cancer treatment that’s right for them, according to Dr. Sara Hurvitz.

While it is the responsibility of the clinician to inform their patients of all options available, it is, in turn, vital for them to play a role in selecting the cancer treatment that’s right for them, according to Dr. Sara Hurvitz.

In an interview with CURE, Hurvitz, an associate professor of medicine at the University of California, Los Angeles, explained how doctors may educate and recommend various treatment options, but ultimately, patients are the ones who need to weigh their options and decide on the best course of therapy.

Transcript:

In my opinion, it’s imperative and ethical to have patients play a role in all of the treatment decisions. These are the people who are going to be assuming all of the toxicity and side effects — and the benefits, frankly – of a given therapy.

We as clinicians, it’s my opinion, that we need to educate our patients and empower them to help them make a decision. It’s certainly our responsibility as clinicians to make a recommendation for the treatment that has the best therapeutic index, meaning highest efficacy and lowest toxicity. But ultimately, the patient is the one that needs to buy in and decide which therapy they would like to proceed with.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Imiage of two doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Related Content